Funding Opportunities

The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.

Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.
 

Notice of Funding Opportunities

Title Announcement Number Activity Code Clinical Trials Status Expiration Date Program Official
Notice of Special Interest (NOSI): Research on the Etiology, Early Detection, Screening and Prevention of Early-Onset Colorectal Cancer NOT-CA-23-018 09/08/2024 Gary Della'Zanna, D.O., M.Sc.
Notice of Special Interest: Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) NOT-OD-22-202 Clinical Trial Not Allowed 04/16/2025 Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D.
Notice of Special Interest (NOSI): Administrative Supplement to Support the NCI Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Research NOT-CA-24-047 06/14/2024 Vignesh Gunasekharan, Ph.D.
Cancer Prevention and Control Clinical Trials Grant Program PAR-24-072 (R01 Clinical Trial Required) R01 Clinical Trial Required 01/08/2027 Brandy Heckman-Stoddard, Ph.D., M.P.H.
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis PAR-24-085 (R01 Clinical Trial Required) R01 Clinical Trial Required 01/08/2027 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Cancer Prevention and Control Clinical Trials Planning Grant Program PAR-22-173 (R34 Clinical Trials Optional) R34 05/08/2025 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Cancer Prevention and Control Clinical Trials Planning Grant Program PAR-22-174 (U34 Clinical Trials Optional) U34 05/08/2025 Brandy Heckman-Stoddard, Ph.D., M.P.H.
The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research PAR-24-153 (K12 Clinical Trial Optional) K12 Clinical Trial Optional 02/19/2027 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer PAR-22-061 (R01 Clinical Trial Not Allowed) R01 Clinical Trial Not Allowed 01/08/2025 Young Kim, Ph.D.
Notice of Special Interest: Administrative Supplements to Support Collection of Spanish Normative Data and Determination of Test-Retest Reliability Estimates of Neuropsychological Tests for NCI Clinical Trials NOT-CA-24-040 06/22/2024 Cecilia Lee, Dr.P.H., R.N.